EUVIMEDEUVIMED entdecken
Crossref

Binding of direct oral anticoagulants to the FA1 site of human serum albumin

Giovanna De Simone iD, Andrea Pasquadibisceglie iD, Alessandra di Masi iD, Valeria Buzzelli, Viviana Trezza iD, Gabriele Macari iD, Fabio Polticelli iD, Paolo Ascenzi iD

Journal of Molecular Recognition · 2021-03 · 34 (3)

DOI: 10.1002/jmr.2877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Recognition, online erschienen am 09.10.2020. Verfasst von Giovanna De Simone und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sciences, Roma Tre University, Rome, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The anticoagulant therapy is widely used to prevent and treat thromboembolic events. Until the last decade, vitamin K antagonists were the only available oral anticoagulants; recently, direct oral anticoagulants (DOACs) have been developed. Since 55% to 95% of DOACs are bound to plasma proteins, the in silico docking and ligand‐binding properties of drugs apixaban, betrixaban, dabigatran, edoxaban, and rivaroxaban and of the prodrug dabigatran etexilate to human serum albumin (HSA), the most abundant plasma protein, have been investigated. DOACs bind to the fatty acid (FA) site 1 (FA1) of ligand‐free HSA, whereas they bind to the FA8 and FA9 sites of heme‐Fe(III)‐ and myristic acid‐bound HSA. DOACs binding to the FA1 site of ligand‐free HSA has been validated by competitive inhibition of heme‐Fe(III) recognition. Values of the dissociation equilibrium constant for DOACs binding to the FA1 site (ie, calc K DOAC ) derived from in silico docking simulations (ranging between 1.2 × 10 −8 M and 1.4 × 10 −6 M) agree with those determined experimentally from competitive inhibition of heme‐Fe(III) binding (ie, exp K DOAC ; ranging between 2.5 × 10 −7 M and 2.2 × 10 −6 M). In addition, this study highlights the inequivalence of rivaroxaban binding to mammalian serum albumin. Given the HSA concentration in vivo (~7.5 × 10 −4 M), values of K DOAC here determined indicate that the formation of the HSA:DOACs complexes in the absence and presence of FAs and heme‐Fe(III) may occur in vivo. Therefore, HSA appears to be an important determinant for DOACs transport.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Binding SitesFactor Xa InhibitorsFatty AcidsHumansModels, MolecularMolecular Docking SimulationProtein ConformationRivaroxabanSerum Albumin, HumanTherapeutic Equivalency

Stichwörter der Autor:innen

competitive inhibition of heme bindingdirect oral anticoagulantshuman serum albuminhuman serum albumin:direct oral anticoagulant recognitionmolecular docking

Substanzen

Factor Xa InhibitorsFatty AcidsRivaroxabanSerum Albumin, Human

Autor:innen und Institutionen

  • Department of Sciences, Roma Tre University, Rome, Italy.
  • Roma Tre Section, National Institute of Nuclear Physics, Rome, Italy.
  • Interdepartmental Laboratory for Electron Microscopy, Roma Tre University, Rome, Italy.

ORCID-Profile: Giovanna De Simone, Andrea Pasquadibisceglie, Alessandra di Masi, Viviana Trezza, Gabriele Macari, Fabio Polticelli, Paolo Ascenzi

Zitieren

APA

De Simone, G., Pasquadibisceglie, A., di Masi, A., Buzzelli, V., Trezza, V., Macari, G., Polticelli, F., & Ascenzi, P. (2021). Binding of direct oral anticoagulants to the FA1 site of human serum albumin. Journal of Molecular Recognition, 34(3). https://doi.org/10.1002/jmr.2877

Vancouver

De Simone G, Pasquadibisceglie A, di Masi A, Buzzelli V, Trezza V, Macari G, et al. Binding of direct oral anticoagulants to the FA1 site of human serum albumin. Journal of Molecular Recognition. 2021;34(3). doi:10.1002/jmr.2877

BibTeX
@article{DeSimone2021,
  author = {De Simone, Giovanna and Pasquadibisceglie, Andrea and di Masi, Alessandra and Buzzelli, Valeria and Trezza, Viviana and Macari, Gabriele and Polticelli, Fabio and Ascenzi, Paolo},
  title = {Binding of direct oral anticoagulants to the FA1 site of human serum albumin},
  journal = {Journal of Molecular Recognition},
  year = {2021},
  volume = {34},
  number = {3},
  doi = {10.1002/jmr.2877}
}
Kostenlos starten →